Inactive Instrument

Semler Scientific Inc Share Price OTC Bulletin Board

Equities

Medical Equipment, Supplies & Distribution

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Semler Scientific Inc
Sales 2024 * 5.52Cr 458.67Cr Sales 2025 * - Capitalization 16Cr 1.35TCr
Net income 2024 * 1.5Cr 124.64Cr Net income 2025 * - EV / Sales 2024 * 2.94 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
11.7 x
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 75.53%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 70 01/12/01
Director of Finance/CFO 52 01/22/01
Chief Operating Officer - 01/10/01
Members of the board TitleAgeSince
Chairman 59 19/23/19
Director/Board Member 68 13/20/13
Chief Executive Officer 70 01/12/01
More insiders
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
Related indices
More about the company